Skip to main content
. 2022 Apr 14;2022(4):CD013696. doi: 10.1002/14651858.CD013696.pub2

1.5. Analysis.

Comparison 1: Mindfulness training, Outcome 5: Mental health outcomes

Mental health outcomes
Study Depression Anxiety Quality of life Stress Negative affect Other
Davis 2014a Not assessed Not assessed Not assessed Not assessed Depression, Anxiety and Stress Scales (DASS): assessed at 1 month post‐baseline, data only reported for intervention arm Not assessed
Davis 2014b Not assessed Not assessed Not assessed Perceived Stress Scale (PSS): assessed at 6 months post‐quit. Significantly greater reduction in intervention than control arm (P = 0.03) Intervention arm scored 16.2 at baseline and 13.0 at 6 months post‐quit (−3.2); comparator arm scored 17.5 at baseline and 16.9 at 6 months post‐quit (−0.6). This difference was not significant when analysed as intention to treat Not assessed Not assessed
de Souza 2020 Hospital Anxiety and Depression Scale (HAD): assessed at 4 and 12 weeks. No difference across conditions in the change between 4 weeks and 12 weeks (F (3.421) = 17.549; P = 0.074). Intervention arm scored 6.4 at 4 weeks and 6.9 at 12 weeks (+0.5); comparator arm scored 7.6 at 4 weeks and 6.0 at 12 weeks (−1.6) HAD: assessed at 4 and 12 weeks. No difference across conditions in the change between 4 weeks and 12 weeks (F (0.352) = 1.668; P = 0.558). Intervention arm scored 10.4 at 4 weeks and 8.9 at 12 weeks (−1.4); comparator arm scored 9.5 at 4 weeks and 8.7 at 12 weeks (−0.8) Not assessed Not assessed Positive and Negative Affect Scale (PANAS): assessed at 4 and 12 weeks. No difference across conditions in the change between 4 weeks and 12 weeks (F (0.015) = 0.278; P = 0.903). Intervention arm scored 20.3 at 4 weeks and 19.1 at 12 weeks (−1.2); comparator arm scored 19.2 at 4 weeks and 17.7 at 12 weeks (−1.4) Positive affect ‐ PANAS: assessed at 4 and 12 weeks. No difference across conditions in the change between 4 weeks and 12 weeks (F (0.904) = 14.395; P = 0.350). Intervention arm scored 25.9 at 4 weeks and 27.2 at 12 weeks (+1.2); comparator arm scored 25.3 at 4 weeks and 24.6 at 12 weeks (−0.7)
Vidrine 2016 Center for Epidemiologic Studies ‐ Depression Scale (CES‐D): assessed 6 times between quit date and 6 months post‐quit. No significant difference in the change between quit date and 6 months post‐quit between intervention arm and either control arm (CBT: β 0.03, 95% CI −0.16 to 0.22, P = 0.762; usual care: β −0.18, 95% CI −0.40 to 0.03, P = 0.099) Not assessed Not assessed 4‐item Perceived Stress Scale ‐ Short Form (PSS‐SF): assessed 6 times between quit date and 6 months post‐quit. No significant difference in the change between quit date and 6 months post‐quit between intervention arm and either control arm (CBT: β 0.09, 95% CI −0.10 to 0.28, P = 0.362; usual care: β −0.16, 95% CI −0.38 to 0.05, P = 0.141) PANAS: assessed 6 times between quit date and 6 months post‐quit. No significant difference in the change between quit date and 6 months post‐quit between intervention arm and either control arm (CBT: β 0.08, 95% CI ‐0.11 to 0.27, p = 0.403; usual care: β ‐0.19, 95% CI ‐0.40 to 0.03, p = 0.086) Positive affect ‐ PANAS: assessed 6 times between quit date and 6 months post‐quit. No significant difference in the change between quit date and 6 months post‐quit between intervention arm and either control arm (CBT: β ‐0.09, 95% CI ‐0.29 to 0.10, p = 0.337; usual care: β 0.09, 95% CI ‐0.13 to 0.30, p = 0.444)